Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
$1.05B |
| 2 |
Peloton Interactive
PTON
|
$691M |
| 3 |
DoorDash
DASH
|
$456M |
| 4 |
Certara
CERT
|
$393M |
| 5 |
Service Corp International
SCI
|
$374M |
Top Sells
| 1 |
Alibaba
BABA
|
$2.33B |
| 2 |
Tesla
TSLA
|
$1.55B |
| 3 |
Moderna
MRNA
|
$1.41B |
| 4 |
Amazon
AMZN
|
$884M |
| 5 |
NetEase
NTES
|
$692M |
Sector Composition
| 1 | Consumer Discretionary | 27.71% |
| 2 | Healthcare | 26.02% |
| 3 | Technology | 19.32% |
| 4 | Communication Services | 12.04% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
151
DELISTED
Rubius Therapeutics, Inc
RUBY
| $83.9M | 0.04% |
4,693,832
-1,190
| -0% | -$21.3K |
|
152
Procter & Gamble
PG
$370B
| $83.4M | 0.04% |
596,802
+3,602
| +0.6% | +$504K |
|
153
AeroVironment
AVAV
$11.9B
| $78.4M | 0.04% |
908,296
-10,551
| -1% | -$911K |
|
154
Joby Aviation
JOBY
$11.2B
| $77.2M | 0.04% |
+7,677,200
| New | +$77.2M |
|
155
LivePerson
LPSN
$86M
| $75M | 0.04% |
1,272,007
-18,178
| -1% | -$1.07M |
|
|
AGR
156
DELISTED
Avangrid, Inc.
AGR
| $74.1M | 0.04% |
1,524,614
+7,875
| +0.5% | +$383K |
|
157
Prologis
PLD
$103B
| $72.8M | 0.04% |
580,341
-20,660
| -3% | -$2.59M |
|
|
DRE
158
DELISTED
Duke Realty Corp.
DRE
| $68.7M | 0.04% |
1,434,182
-50,810
| -3% | -$2.43M |
|
159
iRobot
IRBT
$100M
| $68M | 0.04% |
865,948
-1,172
| -0.1% | -$92K |
|
160
PepsiCo
PEP
$203B
| $67.7M | 0.04% |
450,336
-1,094
| -0.2% | -$165K |
|
161
First Industrial Realty Trust
FR
$6.87B
| $67.4M | 0.04% |
1,293,601
-45,720
| -3% | -$2.38M |
|
162
Rexford Industrial Realty
REXR
$9.7B
| $67.3M | 0.04% |
1,185,373
-42,076
| -3% | -$2.39M |
|
163
Infosys
INFY
$69B
| $67M | 0.04% |
3,012,266
+368,876
| +14% | +$8.21M |
|
164
MakeMyTrip
MMYT
$9.52B
| $67M | 0.04% |
2,462,730
-7,785
| -0.3% | -$212K |
|
|
ADAP
165
Adaptimmune Therapeutics
ADAP
$13.9M
| $66.3M | 0.03% |
12,824,980
+1,128,061
| +10% | +$5.83M |
|
|
ZUO
166
DELISTED
Zuora, Inc.
ZUO
| $65.1M | 0.03% |
3,924,037
-38,457
| -1% | -$638K |
|
167
AbCellera Biologics
ABCL
$1.19B
| $64.9M | 0.03% |
3,240,543
+515,346
| +19% | +$10.3M |
|
168
LiveRamp
RAMP
$1.8B
| $64.8M | 0.03% |
1,371,902
-8,768
| -0.6% | -$414K |
|
|
VEDL
169
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $63.9M | 0.03% |
4,182,806
+42,371
| +1% | +$647K |
|
|
HUYA
170
Huya Inc
HUYA
$841M
| $63.7M | 0.03% |
7,632,744
-1,600,164
| -17% | -$13.3M |
|
171
Bilibili
BILI
$9.2B
| $63.5M | 0.03% |
960,316
-5,178,396
| -84% | -$343M |
|
172
Cardlytics
CDLX
$53.8M
| $62.6M | 0.03% |
745,804
+253,936
| +52% | +$21.3M |
|
173
NextEra Energy, Inc.
NEE
$148B
| $62.4M | 0.03% |
794,623
+4,490
| +0.6% | +$353K |
|
174
Apple
AAPL
$3.54T
| $60.5M | 0.03% |
427,782
+67
| +0% | +$9.48K |
|
175
iShares Silver Trust
SLV
$20.2B
| $59.4M | 0.03% |
2,787,200
+293,600
| +12% | +$6.26M |
|